ATE344032T1 - Polyenoxazole mit antitumorwirkung und verfahren zu deren herstellung mittels eines streptomyces- stamms - Google Patents

Polyenoxazole mit antitumorwirkung und verfahren zu deren herstellung mittels eines streptomyces- stamms

Info

Publication number
ATE344032T1
ATE344032T1 AT04737813T AT04737813T ATE344032T1 AT E344032 T1 ATE344032 T1 AT E344032T1 AT 04737813 T AT04737813 T AT 04737813T AT 04737813 T AT04737813 T AT 04737813T AT E344032 T1 ATE344032 T1 AT E344032T1
Authority
AT
Austria
Prior art keywords
polyenoxazoles
production
antitumor effect
streptomyces strain
obtaining
Prior art date
Application number
AT04737813T
Other languages
German (de)
English (en)
Inventor
James B Mcalpine
Chris M Farnet
Emmanuel Zazopoulos
Nargis Ismail
Brian O Bachmann
Original Assignee
Ecopia Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecopia Biosciences Inc filed Critical Ecopia Biosciences Inc
Application granted granted Critical
Publication of ATE344032T1 publication Critical patent/ATE344032T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/60—Streptomyces sparsogenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT04737813T 2003-06-13 2004-06-14 Polyenoxazole mit antitumorwirkung und verfahren zu deren herstellung mittels eines streptomyces- stamms ATE344032T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47793103P 2003-06-13 2003-06-13

Publications (1)

Publication Number Publication Date
ATE344032T1 true ATE344032T1 (de) 2006-11-15

Family

ID=33551785

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04737813T ATE344032T1 (de) 2003-06-13 2004-06-14 Polyenoxazole mit antitumorwirkung und verfahren zu deren herstellung mittels eines streptomyces- stamms

Country Status (7)

Country Link
US (2) US7312339B2 (enExample)
EP (1) EP1633352B1 (enExample)
JP (1) JP2006527208A (enExample)
AT (1) ATE344032T1 (enExample)
CA (1) CA2470935A1 (enExample)
DE (1) DE602004003056D1 (enExample)
WO (1) WO2004110439A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2512240T3 (es) * 2009-07-14 2014-10-23 Takasago International Corporation Método para preparar espilantol y producto intermedio para su preparación
CN107478670B (zh) * 2017-08-08 2018-04-03 中国环境科学研究院 一种沉积物中肌醇磷酸盐与腐殖酸相互作用的分析方法
CN112067647B (zh) * 2020-11-11 2021-01-15 东南大学 一种检测液体生物样本葡萄糖含量的弛豫核磁共振方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364198A (en) * 1964-10-12 1968-01-16 Upjohn Co Process for the production of n6-methyltubercidin and intermediate
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
JPS6081184A (ja) * 1983-10-11 1985-05-09 Banyu Pharmaceut Co Ltd 抗腫瘍性抗生物質及びその製法
JPS61172881A (ja) * 1985-01-26 1986-08-04 Meiji Seika Kaisha Ltd 新抗生物質キューロマイシンａ又はｂとその製造法
US5039660A (en) 1988-03-02 1991-08-13 Endocon, Inc. Partially fused peptide pellet
JPH08176116A (ja) * 1994-12-27 1996-07-09 Rikagaku Kenkyusho 新規抗生物質スパロキソマイシン
JP2003514033A (ja) * 1999-11-15 2003-04-15 パーカー ヒューズ インスティテュート 癌治療用のホルボキサゾール誘導体

Also Published As

Publication number Publication date
EP1633352A1 (en) 2006-03-15
DE602004003056D1 (de) 2006-12-14
JP2006527208A (ja) 2006-11-30
WO2004110439A1 (en) 2004-12-23
US7312339B2 (en) 2007-12-25
US20090069396A1 (en) 2009-03-12
CA2470935A1 (en) 2004-12-13
US20050038090A1 (en) 2005-02-17
EP1633352B1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
NO2020010I1 (no) fostamatinib eller et farmasøytisk akseptabelt salt av fostamatinib, eller et hydrat, solvat eller N-oksid av fostamatinib eller det farmasøytisk akseptable saltet av fostamatinib, spesielt fostamatinib dinatrium, eventuelt på form av et hydrat
ATE175676T1 (de) Propiophenon-derivate und verfahren zur ihrer herstellung
CY1119381T1 (el) Παραγωγα 2-μεθυλομορφολινο πυριδο-, πυραζο- και πυριμιδο-πυριμιδινης ως αναστολεις mtor
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
NO20054224L (no) Nye 2-pyridinkarboksamidderivater
AR028833A1 (es) Compuestos inhibidores de metaloproteasas, composiciones farmaceuticas, uso para la manufactura de medicamentos, metodo de tratamiento y procedimiento para su preparacion
EP1380564A4 (en) BINAPHTOL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
EE200200466A (et) 8,8a-dihürdroindeno[1,2-d]tiasooli derivaadid, mis on asendatud 8a-asendis, nende valmistamismeetodja kasutamine ravimitena, näiteks anorektiliste toimeainetena
BRPI0409959A (pt) uso de derivados de azetidinacarboxamida em terapia
DE602004003056D1 (de) Polyenoxazole mit antitumorwirkung und verfahren zu deren herstellung mittels eines streptomyces-stamms
NO20062255L (no) 4-anilino-3-kinolinkarbonitriler for behandling av kronisk myelogenos leukemi (CML)
WO2003057213A3 (en) Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor
HUP0203812A2 (hu) Eljárás ciklusos aminosavak sztereoszelektív előállítására
EP1627635A3 (en) Benzothiazolium compounds for use in methods of inhibiting NO production and TNF alpha and treating coronaviral infection
DE60006690D1 (de) Antibiotische caprazamycine und verfahren zu deren herstellung
NO20065873L (no) 3-(4-(2-dihydroisoksazol-3-ylpyridin-5-yl)fenyl)-5-triazol-1-ylmetyloksoazolidin-2-on derivater som MAO inhibitorer i behandlingen av bakterielle infeksjoner
NO982927L (no) Biologisk aktive benzotiazolon etanaminer
IL165807A0 (en) Process for preparing epimerized derivatives of k5polysaccharide with a very high degree of sulfati on and new epi k5-n,o-sulfated polysaccharide derivatives
GEP20063758B (en) Benzothia(Dia)Zine Derivatives and Method for Their Use as AMPA Modulators
HUP0300306A2 (hu) Cikliposztinok, eljárás előállításukra és alkalmazásuk
WO2005024025A8 (en) Polyene polyketides and methods of production
TW200621223A (en) Acyclic 1,3-diamines and uses therefor
IS3815A (is) Afleiður fjölhydroxyfimmhringa-efna, framleiðsla þeirra og notkun sem lyfja
ATE123529T1 (de) Substanzen ws 7622 a,b,c und d, deren derivate, verfahren zu deren herstellung sowie deren verwendung.
ATE108480T1 (de) Ws-9326 a, ws-9326b und deren derivate.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties